Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Engraftment Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT01666080
What this trial is testing

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

Who this might be right for
Hematologic DisordersHemoglobinopathiesImmunodeficiencies
Masonic Cancer Center, University of Minnesota 30
Testing effectiveness (Phase 2)Study completedNCT01720264
What this trial is testing

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaHematopoetic Myelodysplasia+2 more
Sherif S. Farag 15
Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Not applicableNo Longer AvailableNCT02258490
What this trial is testing

Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation

Who this might be right for
Chronic Myeloid LeukemiaMyelodysplastic SyndromeAcute Myeloid Leukemia
Emory University
Early research (Phase 1)Study completedNCT00028236
What this trial is testing

Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)

Who this might be right for
Severe Combined Immunodeficiency
National Institute of Allergy and Infectious Diseases (NIAID) 3
Early research (Phase 1)Active Not RecruitingNCT02500849
What this trial is testing

Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients

Who this might be right for
HIV
City of Hope Medical Center 12
Testing effectiveness (Phase 2)UnknownNCT01757145
What this trial is testing

Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation

Who this might be right for
Hematological MalignancyBone Marrow Failure Syndrome
Rabin Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00003838
What this trial is testing

Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

Who this might be right for
Myeloproliferative DisordersAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 202
Testing effectiveness (Phase 2)Ended earlyNCT00827099
What this trial is testing

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+2 more
Northside Hospital, Inc. 5
Testing effectiveness (Phase 2)Ended earlyNCT02963064
What this trial is testing

JSP191 Antibody Targeting Conditioning in SCID Patients

Who this might be right for
SCID
Jasper Therapeutics, Inc. 23
Testing effectiveness (Phase 2)Ended earlyNCT04083170
What this trial is testing

Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers

Who this might be right for
Acute Erythroid LeukemiaAcute Lymphoblastic LeukemiaAcute Megakaryoblastic Leukemia+8 more
Fred Hutchinson Cancer Center 1
Early research (Phase 1)Study completedNCT00092937
What this trial is testing

Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant

Who this might be right for
Granulomatous DiseaseChronic
National Institute of Allergy and Infectious Diseases (NIAID) 2
Large-scale testing (Phase 3)Study completedNCT01471444
What this trial is testing

Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Who this might be right for
Disorder Related to Bone Marrow TransplantationLeukemiaTransplantation Infection
M.D. Anderson Cancer Center 256
Testing effectiveness (Phase 2)Looking for participantsNCT04784052
What this trial is testing

Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab

Who this might be right for
Fanconi Anemia
Porteus, Matthew, MD 18
Early research (Phase 1)Study completedNCT00005785
What this trial is testing

Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer

Who this might be right for
Hematologic NeoplasmHIV Infection
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Testing effectiveness (Phase 2)Study completedNCT00006417
What this trial is testing

Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 10
Very early researchEnded earlyNCT00394316
What this trial is testing

Gene Therapy for Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 3
Testing effectiveness (Phase 2)WithdrawnNCT02177760
What this trial is testing

Sirolimus Prophylaxis for aGVHD in TME SCID

Who this might be right for
Severe Combined ImmunodeficiencyTransplacental Maternal EngraftmentStem Cell Transplant
University of California, San Francisco
Early research (Phase 1)Looking for participantsNCT07321626
What this trial is testing

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

Who this might be right for
Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Delayed Platelet Engraftment+1 more
First Affiliated Hospital of Zhejiang University 130
Early research (Phase 1)UnknownNCT05005299
What this trial is testing

Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute, L1Leukemia, Lymphoblastic, Acute, L2+3 more
Melbourne Health 18
Next Page